Carrabin N, Cordier M-P, Gaucherand P
Pavillon K, hôpital Edouard-Herriot, 8, place d'Arsonval, 69008 Lyon, France.
J Gynecol Obstet Biol Reprod (Paris). 2007 Jun;36(4):409-12. doi: 10.1016/j.jgyn.2007.03.007. Epub 2007 Apr 18.
Two patients, with prior affected children with Neonatal Haemochromatosis [NH], benefited from intravenous immunoglobulin treatment during their following pregnancy in order to prevent recurrent NH. Whereas NH is a severe disease with high risk of recurrence and high mortality rate (about 80%), a recent treatment was suggested in the USA, which seems to completely modify the prognosis of this pathology. We proposed this treatment for two patients with indeed apparent benefit, giving birth to two healthy babies.
两名患者之前生育过患有新生儿血色病（NH）的孩子，她们在后续妊娠期间接受了静脉注射免疫球蛋白治疗，以预防NH复发。虽然NH是一种严重疾病，复发风险高且死亡率高（约80%），但美国最近提出了一种治疗方法，似乎能彻底改变这种病症的预后。我们为两名患者采用了这种治疗方法，确实取得了明显疗效，她们都生下了健康的宝宝。
